Ovid Therapeutics Inc Total Liabilities

Latest as of June 2026: $22.08 Million USD

Ovid Therapeutics Inc total liabilities. Based on the latest financial reports, Ovid Therapeutics Inc (OVID) has total liabilities worth $22.08 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Ovid Therapeutics Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Ovid Therapeutics Inc (2014–2025)

Total liabilities of Ovid Therapeutics Inc from 2014 to 2025. This chart illustrates how Ovid Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Ovid Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Ovid Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Ovid Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
HeNan Splendor Science & Technology Co Ltd SHE:002296	China	CN¥802.43 Million
Zhejiang Tiancheng Control Co SHG:603085	China	CN¥2.57 Billion
Jinxiandai Information Industry Co SHE:300830	China	CN¥116.33 Million
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	China	CN¥322.95 Million
Xinhua Winshare Publishing and Media Co. Ltd F:SXV	Germany	€7.99 Billion
Golden Eagle Energy Tbk JK:SMMT	Indonesia	Rp1.89 Trillion
Beijing Trust Far Tech SHE:300231	China	CN¥899.62 Million
Anpec Electronics TWO:6138	Taiwan	NT$1.74 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Ovid Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see OVID total asset value.

Liquidity & Leverage Metrics

Ovid Therapeutics Inc Total Liabilities Ratios Explained

Ovid Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	12.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ovid Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ovid Therapeutics Inc (2014–2025)

The table below shows the annual total liabilities of Ovid Therapeutics Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	$20.27 Million	-15.32%
2024-12-31	$23.94 Million	-57.42%
2023-12-31	$56.23 Million	+144.55%
2022-12-31	$22.99 Million	+55.38%
2021-12-31	$14.80 Million	-54.18%
2020-12-31	$32.29 Million	+198.46%
2019-12-31	$10.82 Million	+22.34%
2018-12-31	$8.84 Million	+46.89%
2017-12-31	$6.02 Million	+61.28%
2016-12-31	$3.73 Million	+61.68%
2015-12-31	$2.31 Million	+1825.09%
2014-12-31	$119.95K	--

About Ovid Therapeutics Inc

NASDAQ:OVID USA Biotechnology

Market Cap

$503.87 Million

Market Cap Rank

#11885 Global

#2995 in USA

Share Price

$2.58

Change (1 day)

-5.84%

52-Week Range

$1.20 - $2.96

All Time High

$15.00